2025年5月期 決算説明資料

This document is the financial results presentation for the fiscal year ending May 2025, announced on July 18, 2025. The total revenue reached 6,077 million yen, marking a 15.7% increase compared to the previous year. However, the net loss attributable to parent company shareholders was 68 million yen, primarily due to segment losses from the pre-disease and prevention platform business and special losses from asset impairment. Operating profit decreased by 66.9% to 98 million yen, while selling, general and administrative expenses increased by 21%. The document also discusses future strategies and forecasts for the fiscal year ending May 2026.